Faculty Opinions recommendation of Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
Year: 2017
Type: peer-review
Author: Paul Drawz
Institution: University of Minnesota
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4247452923